Related Experiment Video
Updated: May 13, 2025

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
2.5K
MRI-based deep transfer learning models for predicting progesterone receptor expression in meningioma
1Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Frontiers in Oncology
|April 15, 2025
Summary
Deep transfer learning accurately predicts progesterone receptor (PR) expression in meningioma. The support vector machine (SVM) model demonstrated superior performance, offering a valuable tool for meningioma evaluation and treatment planning.
Area of Science:
- Neuro-oncology
- Biomarker Discovery
- Artificial Intelligence in Medicine
Background:
- Progesterone receptor (PR) expression is a critical biomarker in meningiomas, impacting tumor behavior and treatment strategies.
- Accurate prediction of PR status is essential for personalized patient management.
Purpose of the Study:
- To develop and validate a deep transfer learning (DTL) model for predicting PR expression in meningiomas.
- To assess the performance of different machine learning models in classifying PR status.
Main Methods:
- Utilized a dataset of 307 meningioma patients (173 PR-positive, 134 PR-negative).
- Extracted DTL features using a fine-tuned ResNet 50 model, followed by feature selection using ICC, Spearman correlation, and LASSO.
- Developed predictive models using logistic regression (LR), support vector machine (SVM), and naive Bayes, evaluating performance with ROC analysis, AUC, accuracy, sensitivity, and specificity.
Main Results:
- Extracted 2048 DTL features, selecting 35 for model construction.
- Achieved AUC values of 0.819 (LR), 0.83 (Naive Bayes), and 0.842 (SVM) in the test set.
- The SVM model demonstrated superior predictive performance and clinical utility, as indicated by decision curve analysis.
Conclusions:
- The developed SVM model, based on DTL features, effectively predicts PR expression in meningiomas.
- This AI-driven approach offers a promising and non-invasive tool for meningioma evaluation.

